Credit Suisse’s 1Life Healthcare ONEM Stock Holding History

Credit Suisse’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-32,700	Closed	-$575K	–	4498
2021 Q4	$575K	Buy	32,700 +10,400	+47%	+$202K	﹤0.01%	3713
2021 Q3	$452K	Hold	22,300	–	–	﹤0.01%	3868
2021 Q2	$737K	Hold	22,300	–	–	﹤0.01%	3595
2021 Q1	$871K	Buy	+22,300	New	+$1.05M	﹤0.01%	3410

Credit Suisse's ONEM Position: Q1 2023 in Review

Credit Suisse sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 353,675 shares — an estimated $5.91M sold.

Credit Suisse first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $142M in Q1 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Credit Suisse reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 353,675 1Life Healthcare shares in Q1 2023, an estimated $5.91M.
Credit Suisse first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
Credit Suisse's 1Life Healthcare position peaked at $142M in Q1 2021.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.